Published in Clin Infect Dis on May 01, 1995
Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev (2012) 1.84
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med (2011) 1.32
Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group. Antimicrob Agents Chemother (1998) 0.75
Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother (1985) 4.07
Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant (2000) 2.65
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]. Infection (1977) 2.54
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000. Antimicrob Agents Chemother (1979) 2.23
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21
Clinical evaluation of a Mycobacterium tuberculosis PCR assay. J Clin Microbiol (1995) 2.19
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J (1996) 2.18
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol (1986) 2.00
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest (1998) 1.95
Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol (1985) 1.86
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother (2000) 1.80
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. Eur Respir J (1995) 1.61
Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. Eur Respir J (1995) 1.52
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49
Comparative pharmacokinetics of cefoperazone and cefotaxime. Clin Ther (1980) 1.46
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]. Dtsch Med Wochenschr (2008) 1.45
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora. Antimicrob Agents Chemother (1983) 1.39
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol (2004) 1.39
Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J (2006) 1.29
Comparative pharmacokinetics of apalcillin and piperacillin. Antimicrob Agents Chemother (1984) 1.28
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J (2006) 1.28
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis (2000) 1.27
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin]. Antimicrob Agents Chemother (1975) 1.26
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J (2003) 1.24
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium. Antimicrob Agents Chemother (1999) 1.24
Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography. Antimicrob Agents Chemother (1982) 1.19
Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Antimicrob Agents Chemother (1996) 1.19
Modulation of LTP at rat hippocampal CA3-CA1 synapses by direct current stimulation. J Neurophysiol (2012) 1.17
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis (1992) 1.17
Determination of cefmenoxime in human body fluids by high-performance liquid chromatography. Eur J Clin Microbiol (1983) 1.08
Multiple dose pharmacokinetics and therapeutic results with ceftazidime. J Antimicrob Chemother (1983) 1.07
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med (1997) 1.05
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04
Glutathione S-transferase M1 genotype and age-related cataracts. Lack of association in an Italian population. Invest Ophthalmol Vis Sci (1996) 1.03
Amplification of Mycobacterium tuberculosis from peripheral blood. J Clin Microbiol (1995) 1.03
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob Agents Chemother (1983) 1.03
Toxicity of quinolones. Drugs (1999) 1.03
Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers. J Antimicrob Chemother (1992) 1.02
Course of autism signs in the first year of life. Psychopathology (2005) 1.02
Reference values of maximal respiratory mouth pressures: a population-based study. Am Rev Respir Dis (1992) 1.02
Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J (1997) 1.01
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis (1996) 1.01
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Antimicrob Agents Chemother (1992) 1.00
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1989) 1.00
Biliary excretion and pharmacokinetics of cefoperazone in humans. J Antimicrob Chemother (1983) 0.99
Elimination of ampicillin and gentamicin by hemofiltration. Klin Wochenschr (1979) 0.99
Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism. Neuroscience (2010) 0.99
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. Am Rev Respir Dis (1988) 0.98
Lymphocyte subsets in peripheral blood and smoking habits. Lung (1997) 0.98
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study. J Antimicrob Chemother (1980) 0.98
Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers. Antimicrob Agents Chemother (1988) 0.97
Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media. Eur Respir J (1995) 0.97
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids. J Clin Chem Clin Biochem (1986) 0.97
Meropenem: clinical response in relation to in vitro susceptibility. Clin Microbiol Infect (2000) 0.96
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J (2004) 0.96
Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci (1994) 0.96
Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun (2006) 0.96
Carbapenems in clinical practice: a guide to their use in serious infection. Int J Antimicrob Agents (1999) 0.96
Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J Chromatogr (1992) 0.96
Smoking habit and bronchial reactivity in normal subjects. A population-based study. Am Rev Respir Dis (1989) 0.95
Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) (1985) 0.95
Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. Respiration (1996) 0.94
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis (1976) 0.94
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. Respir Med (2004) 0.93
The action of new antituberculous drugs on intracellular tubercle bacilli. Antibiot Chemother (1970) 0.93
Feasibility and validation of telespirometry in general practice: The Italian "Alliance" study. Respir Med (2009) 0.92
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother (1994) 0.92
Determination of linezolid in human serum and urine by high-performance liquid chromatography. Int J Antimicrob Agents (2001) 0.92
Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med (2000) 0.92
Cefepime: overview of activity in vitro and in vivo. J Antimicrob Chemother (1993) 0.91
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis (2005) 0.91
Significance of non-pneumophila Legionella species in adult community-acquired and nosocomial pneumonias. Klin Wochenschr (1987) 0.91
Fluoroquinolones: interaction profile during enteral absorption. Drugs (1993) 0.91
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine (2005) 0.90
Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects. Gerontology (1994) 0.90
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study. Infection (2006) 0.89
Sympathetically-induced development of tension in jaw muscles: the possible contraction of intrafusal muscle fibres. Pflugers Arch (1985) 0.89
MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur Respir J (1996) 0.89
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate. Antimicrob Agents Chemother (1997) 0.88
[Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)]. Arzneimittelforschung (1980) 0.88
Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling. Crit Care (2001) 0.88
Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection (2000) 0.87
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers. Drugs (1988) 0.87
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi). Haematologica (1997) 0.87
Determination of trovafloxacin in human body fluids by high-performance liquid chromatography. J Chromatogr A (1999) 0.87
Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole. Antimicrob Agents Chemother (1990) 0.87
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur Respir J (1992) 0.87
Therapeutic aminoglycoside monitoring in renal failure patients. Ther Drug Monit (1987) 0.87
Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes. Eur Respir J (1997) 0.86
Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease. Eur J Drug Metab Pharmacokinet (1985) 0.86
Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clin Infect Dis (1993) 0.86
Pharmacokinetics of FCE 22891, a new oral penem. Antimicrob Agents Chemother (1990) 0.86
Comparative clinical pharmacology of three ampicillins and amoxicillin administered orally. J Infect Dis (1974) 0.86
Auditory steady-state responses to click trains from the rat temporal cortex. Clin Neurophysiol (1999) 0.86
Pneumococcal vaccination. Eur Respir J (2005) 0.86
[A Q fever epidemic in Berlin. The epidemiological and clinical aspects]. Dtsch Med Wochenschr (1993) 0.86
[Diagnosis and antibiotic treatment of infectious diseases in general practice. Results of an inquiry]. Dtsch Med Wochenschr (1983) 0.86